Nasdaq $5 Million Minimum Offering Proceeds Rule: What IPO and OTC Uplisting Companies Need to Know
Nasdaq’s initial listing liquidity rules changed earlier this year, and the changes are particularly important for small-cap companies, OTC issuers seeking to uplist to Nasdaq, foreign private issuers, and companies planning an initial public offering. The rule is often described as Nasdaq’s “$5 million net capital” rule or “$5 million raise” requirement. Those descriptions are useful shorthand, but they are not technically precise.
The rule is better understood as a change to Nasdaq’s Market Value of Unrestricted Publicly Held Shares, or MVUPHS, requirements. For Nasdaq Capital Market applicants listing under the Net Income Standard, the applicable minimum MVUPHS requirement is $5 million. For IPOs and certain OTC uplistings, Nasdaq now requires that the applicable MVUPHS requirement be satisfied from the proceeds of the public offering, rather than from resale shares or legacy public float.
For companies going public or uplisting from the OTC market, the practical result is straightforward: if the company cannot rely on the required OTC trading volume and instead uses the firm commitment underwritten public offering alternative, a Nasdaq Capital Market uplisting generally requires an offering of at least $5 million, and a Nasdaq Global Market uplisting generally requires an offering of at least $8 million. In some cases, the required raise may be higher depending on the Nasdaq listing standard selected.
When Did the Nasdaq $5 Million Rule Become Effective?
The SEC approved Nasdaq’s rule change on March 12, 2025. The approved filing states that the changes would become operative 30 days after SEC approval. As a result, the operative date was April 11, 2025.
This means that, earlier this year, Nasdaq began applying the amended liquidity rules to covered IPOs and OTC uplistings. Companies that began planning their transactions under the prior rules should revisit their Nasdaq eligibility analysis before filing a registration statement, launching an offering, or submitting a listing application.
What Changed?
Nasdaq amended Listing Rules 5405 and 5505. These rules apply to initial listings on the Nasdaq Global Market and Nasdaq Capital Market. The amended rules require a company listing in connection with an IPO, including through American Depository Receipts, to satisfy the applicable MVUPHS requirement from the proceeds of the offering.
Nasdaq also amended the rules for companies uplisting from the U.S. over-the-counter market. If an OTC company is relying on the public offering alternative to the average daily trading volume requirement, it must satisfy the applicable MVUPHS requirement with only the proceeds of the offering. Nasdaq also increased the required public offering size for that alternative from $4 million to $5 million for Nasdaq Capital Market applicants and to $8 million for Nasdaq Global Market applicants.
Nasdaq explained that resale shares may not contribute to liquidity in the same way as shares sold in a public offering. Nasdaq also stated that companies meeting the MVUPHS requirement through an IPO by including resale shares experienced higher volatility than companies meeting the requirement based only on offering proceeds.
How is the $5 Million Requirement Calculated?
The calculation focuses on the Market Value of Unrestricted Publicly Held Shares, not “net capital.” In the context of an IPO or covered OTC uplisting, the practical calculation is:
MVUPHS = public offering price multiplied by the number of unrestricted publicly held shares sold in the offering
For a Nasdaq Capital Market applicant relying on the Net Income Standard, the company must have at least $5 million in MVUPHS. For a covered IPO or OTC uplisting relying on the firm commitment offering alternative, that amount must come from the offering proceeds.
The lower the offering price, the more shares the company must sell to reach the $5 million threshold. For example, a company pricing at $2.00 per share would need to sell 2,500,000 shares to generate $5 million of offering proceeds. A company pricing at $5.00 per share would need to sell 1,000,000 shares.
This calculation matters because Nasdaq’s amended rule does not permit covered applicants to use resale shares as a substitute for offering proceeds when the rule requires the MVUPHS requirement to be satisfied from the offering. A registration statement that includes a large resale component may still be useful for other purposes, but resale shares generally will not solve the Nasdaq liquidity issue where the amended rule applies.
What Counts as Unrestricted Publicly Held Shares?
Nasdaq defines Unrestricted Publicly Held Shares as shares that are not held by an officer, director, or 10% shareholder and that are not subject to resale restrictions of any kind. This definition is important because not every outstanding share helps satisfy Nasdaq’s liquidity requirements.
Shares held by insiders, control persons, and 10% shareholders generally do not count as publicly held shares. Restricted securities and shares subject to resale limitations also do not count as unrestricted publicly held shares. For IPOs and covered OTC uplistings, Nasdaq’s amended rule adds a further limitation: the applicable MVUPHS requirement must be satisfied from offering proceeds when the rule applies.
What Happens to OTC Uplistings Under the New Rule?
The new rule is especially important for OTC companies seeking to uplist to Nasdaq. Before the amendment, an OTC issuer could satisfy Nasdaq’s trading-related requirement by demonstrating minimum OTC trading activity or, alternatively, by listing in connection with a firm commitment underwritten public offering of at least $4 million.
Under the amended rule, an OTC company must still satisfy the average daily trading volume requirement unless it relies on the firm commitment underwritten offering alternative. If the company uses that alternative, the minimum offering amount is now at least $5 million for Nasdaq Capital Market uplistings and at least $8 million for Nasdaq Global Market uplistings. The issuer must also satisfy the applicable MVUPHS requirement from the offering proceeds.
In practical terms, this means that many thinly traded OTC companies will need to conduct a larger underwritten public offering to uplist to Nasdaq. The rule may also require companies to reassess reverse split planning, offering price, capitalization, dilution, underwriter readiness, and timing.
OTC Uplisting Example
Assume an OTC company wants to uplist to the Nasdaq Capital Market but does not satisfy Nasdaq’s minimum average daily trading volume requirement. If the company relies on the firm commitment public offering alternative, it must complete an offering of at least $5 million and must satisfy the applicable MVUPHS requirement from that offering.
If the offering is priced at $4.00 per share, the issuer must sell at least 1,250,000 shares to reach $5 million. If the offering is priced at $2.00 per share, the issuer must sell at least 2,500,000 shares. If the company qualifies under a Nasdaq standard that requires a higher MVUPHS amount, the minimum offering size must be large enough to satisfy that higher standard.
Why Resale Shares Are Less Useful for Nasdaq Eligibility
The amended rule reduces the ability of companies to rely on resale shares to satisfy Nasdaq’s initial listing liquidity requirements. This is a major issue for companies that file registration statements combining a primary offering with a large resale component.
A resale registration statement may register shares held by existing shareholders for resale, but those shares do not necessarily create new liquidity or capital for the issuer. Nasdaq’s concern is that shares sold in a firm commitment underwritten public offering are more likely to support price discovery and orderly trading at the time of listing than previously issued resale shares.
For Securities Lawyer 101 and Going Public 101 readers, the takeaway is that Nasdaq eligibility should be evaluated based on the actual primary offering and the applicable Nasdaq listing standard, not merely on the number of shares registered in the resale portion of a Form S-1 registration statement.
Impact on Small-Cap IPOs and Companies Going Public
The amended Nasdaq rule affects more than OTC uplistings. It also impacts companies listing on Nasdaq in connection with an IPO. A company conducting an IPO must satisfy the applicable MVUPHS requirement with the proceeds of the offering. This can affect deal size, pricing, dilution, underwriter negotiations, and listing timing.
For small-cap issuers, the rule may make a very small IPO more difficult. If the offering size is too small, Nasdaq may not view the transaction as satisfying the applicable liquidity requirement. Companies should model the required MVUPHS calculation before finalizing the offering structure.
Practical Planning Issues for Issuers
Companies planning a Nasdaq IPO or OTC uplisting should address the amended rule early. Waiting until the listing application is under review can result in delays, revised offering terms, increased dilution, or an inability to satisfy Nasdaq’s initial listing standards.
- Confirm whether the company is applying for the Nasdaq Capital Market or the Nasdaq Global Market.
- Identify the exact Nasdaq initial listing standard the company intends to use.
- Determine whether the applicant is listing in connection with an IPO or uplisting from the OTC market.
- Analyze whether the OTC issuer satisfies the average daily trading volume requirement.
- If relying on the public offering alternative, confirm that the offering is a firm commitment underwritten public offering.
- Calculate the required MVUPHS based on the public offering price and the number of shares sold in the offering.
- Do not assume resale shares will satisfy the Nasdaq liquidity requirement where the amended rule applies.
- Review the impact of reverse splits, offering price, warrants, dilution, and capitalization on listing eligibility.
- Include accurate Nasdaq listing risk factors and disclosure in the registration statement.
- Coordinate early with securities counsel, auditors, transfer agent, underwriter, and Nasdaq listing staff.
Key Takeaways
- The rule became operative on April 11, 2025, following SEC approval on March 12, 2025.
- The rule is commonly described as a $5 million Nasdaq requirement, but the precise concept is MVUPHS.
- For Nasdaq Capital Market applicants using the Net Income Standard, the relevant MVUPHS threshold is $5 million.
- Covered IPOs and OTC uplistings must satisfy the applicable MVUPHS requirement from offering proceeds.
- For OTC uplistings relying on the firm commitment offering alternative, the minimum offering amount increased from $4 million to $5 million for Nasdaq Capital Market applicants.
- For Nasdaq Global Market applicants, the comparable minimum offering amount is $8 million, and higher amounts may apply under other standards.
- Resale shares generally cannot be used to satisfy the amended offering-proceeds-based MVUPHS requirement.
- Companies going public should run the calculation before filing or launching the offering.
Conclusion
Nasdaq’s $5 million minimum offering proceeds rule is part of a broader focus on liquidity, public float, and investor protection in small-cap listings. The rule makes Nasdaq uplisting and IPO planning more technical, particularly for OTC companies with limited trading volume and issuers relying on resale shares in their registration statements.
For companies seeking to list on Nasdaq, the rule should be addressed at the beginning of the going public process. Issuers should confirm whether the amended MVUPHS requirement applies, calculate the required offering size, and ensure that the primary offering proceeds support the applicable Nasdaq listing standard.
Securities Lawyer 101 regularly publishes resources for private companies, OTC issuers, foreign private issuers, and small-cap companies evaluating Form S-1 registration statements, Nasdaq uplistings, and public company readiness. Companies considering a Nasdaq listing should consult experienced securities counsel before launching an IPO or OTC uplisting transaction.
This securities law blog post is provided as a general informational service. If you have any questions about this article, Hamilton & Associates Law Group, P.A. is ready to help.
Since 1998, our Founder, Brenda Hamilton, has been a leading voice in corporate and securities law, representing both domestic and international clients across diverse industries and jurisdictions.
To speak with a Securities Attorney, please contact Brenda Hamilton at 200 E Palmetto Rd, Suite 103, Boca Raton, Florida, (561) 416-8956, or by email at [email protected].
Hamilton & Associates | Securities Attorneys
Brenda Hamilton, Securities Attorney
200 E Palmetto Rd, Suite 103
Boca Raton, Florida 33432
Telephone: (561) 416-8956
Facsimile: (561) 416-2855
www.SecuritiesLawyer101.com